Literature DB >> 18061145

Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior.

Edward G Meloni1, Catherine L Reedy, Bruce M Cohen, William A Carlezon.   

Abstract

BACKGROUND: Parallel lines of research suggest that dysfunction affecting both corticotropin-releasing factor (CRF) and serotonin (5-HT) systems is involved in the pathophysiology of psychiatric illnesses such as anxiety and depression. The effect of CRF on behavior and on the accompanying change in activity of 5-HT neurons in the dorsal and median raphe nuclei (DR and MR) that project to the ventral medial prefrontal cortex (mPFC), a brain area implicated in mood and anxiety disorders, was studied.
METHODS: Male Sprague-Dawley rats with intra-mPFC deposits of fluorescent microspheres received injections of CRF (1 microg, intracerebroventricular [i.c.v.]) and were tested for CRF-enhanced startle, a behavioral assay believed to reflect stress- or anxiety-like states. C-Fos immunohistochemistry was used to measure CRF-induced activity in retrogradely labeled neurons in the DR and MR and correlate this level of activity with the level of CRF-enhanced startle.
RESULTS: The CRF-enhanced startle was accompanied by an increased c-Fos expression in retrogradely labeled cells in the raphe. In the DR and MR, there was a clear topography of activation, with a higher-percent activation in retrogradely labeled neurons in caudal sections. In the caudal DR, this effect was positively correlated with the level of CRF-enhanced startle. Co-expression of retrogradely labeled cells with tryptophan hydroxylase showed that the majority (> 90%) of raphe efferents to the mPFC were from serotonergic neurons.
CONCLUSIONS: These data indicate that CRF activates a subpopulation of cortical-projecting 5-HT raphe neurons and suggest that increased 5-HT release in the mPFC might be an important component driving some types of anxiety-like behaviors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061145      PMCID: PMC2362385          DOI: 10.1016/j.biopsych.2007.10.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  66 in total

Review 1.  Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications.

Authors:  Zhen Yan
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

2.  Differential projections of the infralimbic and prelimbic cortex in the rat.

Authors:  Robert P Vertes
Journal:  Synapse       Date:  2004-01       Impact factor: 2.562

Review 3.  Anatomic and functional topography of the dorsal raphe nucleus.

Authors:  Jolane K Abrams; Philip L Johnson; Jacob H Hollis; Christopher A Lowry
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

Review 4.  Amygdala, medial prefrontal cortex, and hippocampal function in PTSD.

Authors:  Lisa M Shin; Scott L Rauch; Roger K Pitman
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

5.  Projection patterns from the raphe nuclear complex to the ependymal wall of the ventricular system in the rat.

Authors:  K L Simpson; T M Fisher; B D Waterhouse; R C Lin
Journal:  J Comp Neurol       Date:  1998-09-14       Impact factor: 3.215

6.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

7.  Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men.

Authors:  M C Austin; J E Janosky; H A Murphy
Journal:  Mol Psychiatry       Date:  2003-03       Impact factor: 15.992

8.  Interactions between corticotropin-releasing hormone and serotonin: implications for the aetiology and treatment of anxiety disorders.

Authors:  A C E Linthorst
Journal:  Handb Exp Pharmacol       Date:  2005

9.  Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.

Authors:  Daniel R Staub; Andrew K Evans; Christopher A Lowry
Journal:  Brain Res       Date:  2006-01-03       Impact factor: 3.252

Review 10.  The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies.

Authors:  M J Owens; C B Nemeroff
Journal:  Ciba Found Symp       Date:  1993
View more
  26 in total

1.  Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle.

Authors:  B M Spannuth; M W Hale; A K Evans; J L Lukkes; S Campeau; C A Lowry
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

2.  Tracking down the molecular substrates of stress: new roles for p38α MAPK and kappa-opioid receptors.

Authors:  John W Muschamp; Ashlee Van't Veer; William A Carlezon
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

3.  Overexpression of Protein Kinase Mζ in the Prelimbic Cortex Enhances the Formation of Long-Term Fear Memory.

Authors:  Yan-Xue Xue; Zhen-Zhen Zhu; Hai-Bin Han; Jian-Feng Liu; Shi-Qiu Meng; Chen Chen; Jian-Li Yang; Ping Wu; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2015-02-27       Impact factor: 7.853

Review 4.  Understanding behavioral effects of early life stress using the reactive scope and allostatic load models.

Authors:  Brittany R Howell; Mar M Sanchez
Journal:  Dev Psychopathol       Date:  2011-11

5.  Corticotropin-releasing factor, serotonin, and sex: keys to the castle of depressive illness.

Authors:  James I Koenig
Journal:  Endocrinology       Date:  2009-08       Impact factor: 4.736

6.  Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior.

Authors:  Ross A McDevitt; Ryoko Hiroi; Scott M Mackenzie; Nicholas C Robin; Aaron Cohn; Jeansok J Kim; John F Neumaier
Journal:  Biol Psychiatry       Date:  2011-02-26       Impact factor: 13.382

Review 7.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

Review 8.  Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Authors:  Matthew E Glover; Sarah M Clinton
Journal:  Int J Dev Neurosci       Date:  2016-05-07       Impact factor: 2.457

9.  Neurochemical differences between target-specific populations of rat dorsal raphe projection neurons.

Authors:  Eric W Prouty; Daniel J Chandler; Barry D Waterhouse
Journal:  Brain Res       Date:  2017-09-01       Impact factor: 3.252

10.  Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise.

Authors:  Benjamin N Greenwood; Paul V Strong; Leah Brooks; Monika Fleshner
Journal:  Psychopharmacology (Berl)       Date:  2008-05-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.